ROYAL BANK OF CANADA - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 52 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$2,000
-93.5%
4,000
-81.9%
0.00%
Q2 2021$31,000
-32.6%
22,058
-17.0%
0.00%
Q1 2021$46,000
-55.3%
26,573
-67.7%
0.00%
Q4 2020$103,000
-3.7%
82,258
+9.2%
0.00%
Q3 2020$107,000
-2.7%
75,300
-17.4%
0.00%
Q2 2020$110,000
-3.5%
91,170
-5.5%
0.00%
Q1 2020$114,000
-25.0%
96,514
+33.9%
0.00%
Q4 2019$152,000
-33.0%
72,062
-30.1%
0.00%
Q3 2019$227,000
-3.0%
103,134
+11.6%
0.00%
Q2 2019$234,000
-16.4%
92,441
+14.6%
0.00%
Q1 2019$280,000
+87.9%
80,630
+25.5%
0.00%
Q4 2018$149,000
-20.7%
64,270
+31.7%
0.00%
Q3 2018$188,000
+21.3%
48,800
+6.3%
0.00%
Q2 2018$155,000
+64.9%
45,900
+2.3%
0.00%
Q1 2018$94,000
+51.6%
44,865
+47.6%
0.00%
Q4 2017$62,000
-58.1%
30,390
-6.0%
0.00%
Q3 2017$148,000
+604.8%
32,318
+217.4%
0.00%
Q2 2017$21,000
-70.0%
10,182
-53.8%
0.00%
Q1 2017$70,000
+125.8%
22,026
+89.4%
0.00%
Q4 2016$31,000
+675.0%
11,629
+933.7%
0.00%
Q3 2016$4,000
+33.3%
1,1250.0%0.00%
Q2 2016$3,000
+50.0%
1,125
+40.6%
0.00%
Q1 2016$2,000
-33.3%
8000.0%0.00%
Q4 2015$3,000
+50.0%
8000.0%0.00%
Q3 2015$2,000
-89.5%
800
-81.8%
0.00%
Q2 2015$19,000
-51.3%
4,400
-56.2%
0.00%
Q1 2015$39,000
-38.1%
10,047
+6.9%
0.00%
Q4 2014$63,000
-11.3%
9,400
-27.1%
0.00%
Q3 2014$71,000
+26.8%
12,900
+134.5%
0.00%
Q2 2014$56,000
+300.0%
5,500
+358.3%
0.00%
Q1 2014$14,000
+100.0%
1,200
+87.8%
0.00%
Q3 2013$7,0006390.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Perceptive Advisors 6,574,060$27,874,0001.68%
SENZAR ASSET MANAGEMENT, LLC 798,381$3,385,0000.58%
Cormorant Asset Management, LP 850,000$3,604,0000.48%
Palo Alto Investors LP 2,135,739$9,056,0000.40%
Opus Point Partners Management, LLC 99,959$424,0000.34%
Granahan Investment Management 1,582,237$6,709,0000.19%
Joel Isaacson & Co., LLC 70,660$300,0000.08%
MARINER INVESTMENT GROUP LLC 59,700$253,0000.06%
MYCIO WEALTH PARTNERS, LLC 75,000$318,0000.06%
Cornerstone Capital, Inc. 59,200$251,0000.06%
View complete list of ACELRX PHARMACEUTICALS INC shareholders